TapewireFind a company

person · Reporting owner

HOOVER R DAVID

Disclosed activity across 4 companies

Tapewire entity
12235
SEC CIK
0001186033

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
ELI LILLY & CoLLY · Entity 2794DirectorNovember 20, 2017November 22, 2017
Elanco Animal Health IncELAN · Entity 3457DirectorMay 21, 2026May 26, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ELI LILLY & Co

Report date November 20, 2017 · Filed November 22, 2017

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect36,284 Reported balance After 2017-11-20 transaction · row 1
1 source row

Row 1 · 2017-11-20 · Grant · Acquired 1,924 · Balance 36,284

Common StockSEC Table I · non-derivativeIndirectSuzanne A. Hoover Revocable Trust1,500 Reported balance Holding disclosure · report date 2017-11-20 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 1,500

F1: Revocable Trust of which reporting person's spouse is the trustee.

Filing footnotes · ownership attribution and instrument terms

F1: Revocable Trust of which reporting person's spouse is the trustee.

Elanco Animal Health Inc

Report date May 21, 2026 · Filed May 26, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect111,451 Reported balance After 2026-05-21 transaction · row 1
1 source row

Row 1 · 2026-05-21 · Grant · Acquired 4,678 · Balance 111,451

F1: Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Common StockSEC Table I · non-derivativeIndirectRevocable Trust150,000 Reported balance Holding disclosure · report date 2026-05-21 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 150,000

Common StockSEC Table I · non-derivativeIndirectSuzanne A. Hoover Revocable Trust15,920 Reported balance Holding disclosure · report date 2026-05-21 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 15,920

Filing footnotes · ownership attribution and instrument terms

F1: Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

BALL Corp

Report date April 25, 2018 · Filed April 25, 2018

Section 16 reporting ended · disclosed 2018-04-25. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect192,811.0889 Reported balance Holding disclosure · report date 2018-04-25 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 192,811.0889

Common StockSEC Table I · non-derivativeIndirectRDH Trust971,090 Reported balance Holding disclosure · report date 2018-04-25 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 971,090

Deferred Compensation Company Stock PlanSEC Table II · derivative / convertible securityDirect11,152.1288 Reported balance Holding disclosure · report date 2018-04-25 · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · Balance 11,152.1288

F1: Each unit may be settled for a single share of stock or the equivalent amount of cash pursuant to the Ball Corporation Deferred Compensation Company Stock Plan.

F2: Stock units in Ball Corporation's Deferred Compensation Company Stock Plan are distributed upon the separation of service in accordance with the Plan.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect38,542 Reported balance Holding disclosure · report date 2018-04-25 · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · Balance 38,542

F3: Each restricted stock unit represents a contingent right to receive one share of Ball Corporation Common Stock.

Stock Appreciation Rights (sars)SEC Table II · derivative / convertible security · Conversion / exercise price $10.02 · Expires 2019-01-28Direct800,000 Reported balance Holding disclosure · report date 2018-04-25 · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · Balance 800,000

Stock Appreciation Rights (sars)SEC Table II · derivative / convertible security · Conversion / exercise price $12.61 · Expires 2020-01-27Direct516,400 Reported balance Holding disclosure · report date 2018-04-25 · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · Balance 516,400

Stock Option (iso) (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.61 · Expires 2020-01-27Direct13,600 Reported balance Holding disclosure · report date 2018-04-25 · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · Balance 13,600

Filing footnotes · ownership attribution and instrument terms

F1: Each unit may be settled for a single share of stock or the equivalent amount of cash pursuant to the Ball Corporation Deferred Compensation Company Stock Plan.

F2: Stock units in Ball Corporation's Deferred Compensation Company Stock Plan are distributed upon the separation of service in accordance with the Plan.

F3: Each restricted stock unit represents a contingent right to receive one share of Ball Corporation Common Stock.

EDGEWELL PERSONAL CARE Co

Report date February 03, 2021 · Filed February 05, 2021

Section 16 reporting ended · disclosed 2021-02-05. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect46,724 Reported balance After 2021-02-03 transaction · row 1
1 source row

Row 1 · 2021-02-03 · Exercise / conversion · Acquired 20,839 · Balance 46,724

F1: Total of the previously deferred Restricted Stock Equivalents as reported here in Table II converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021.

Restricted Stock EquivalentsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct0 Reported balance After 2021-02-03 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2021-02-03 · Other · Disposed 10,000 · Balance 0

F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021.

Restricted Stock Equivalents 1-3-2017SEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct0 Reported balance After 2021-02-03 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2021-02-03 · Other · Disposed 1,667 · Balance 0

F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021.

Restricted Stock Equivalents 1-2-2018SEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct0 Reported balance After 2021-02-03 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2021-02-03 · Other · Disposed 2,072 · Balance 0

F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021.

Restricted Stock Equivalents 2-1-2019SEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct0 Reported balance After 2021-02-03 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2021-02-03 · Other · Disposed 3,156 · Balance 0

F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021.

Restricted Stock Equivalents 2-6-2020SEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct0 Reported balance After 2021-02-03 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2021-02-03 · Other · Disposed 3,944 · Balance 0

F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021.

Common StockSEC Table I · non-derivativeIndirectSuzanne A. Hoover Revocable Trust10,000 Reported balance Holding disclosure · report date 2021-02-03 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 10,000

Filing footnotes · ownership attribution and instrument terms

F1: Total of the previously deferred Restricted Stock Equivalents as reported here in Table II converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021.

F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 21, 2026 Filed May 26, 2026 20:45 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantCommon Stock 4,678 $0.00 $0.00
Disclosure

SEC source: 0001186033-26-000002 · form4-05262026_080554.xml · nonDerivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,451

F1 · shares: Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
December 19, 2025 Filed Dec 23, 2025 21:03 UTC Elanco Animal Health Inc ELAN · Entity 3457 GiftCommon Stock 60,000 $0.00 $0.00
Disclosure

SEC source: 0001186033-25-000007 · form4-12232025_091249.xml · nonDerivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Revocable Trust

Disclosed balance after: 150,000

F1 · kind: Reported transaction is a gift of shares to a charitable trust.

Read SEC document
November 28, 2025 Filed Dec 2, 2025 22:02 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantCommon Stock 10,314 $0.00 $0.00
Disclosure

SEC source: 0001186033-25-000005 · form4-12022025_101220.xml · nonDerivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,773

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
March 05, 2025 Filed Mar 7, 2025 21:21 UTC Elanco Animal Health Inc ELAN · Entity 3457 PurchaseCommon Stock 25,000 $10.90 $272,557.50
Disclosure

SEC source: 0001415889-25-007410 · form4-03072025_090317.xml · nonDerivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Revocable Trust

Disclosed balance after: 210,000

Read SEC document
November 29, 2024 Filed Dec 3, 2024 22:07 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantCommon Stock 18,169 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-028141 · form4-12032024_101236.xml · nonDerivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,459

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
March 06, 2024 Filed Mar 8, 2024 22:09 UTC Elanco Animal Health Inc ELAN · Entity 3457 PurchaseCommon Stock 20,000 $16.14 $322,808.00
Disclosure

SEC source: 0001415889-24-007385 · form4-03082024_100353.xml · nonDerivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Revocable Trust

Disclosed balance after: 185,000

Read SEC document
December 29, 2023 Filed Jan 3, 2024 21:50 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 2,147.651 $14.90 $32,000.00
Disclosure

SEC source: 0001415889-24-000324 · form4-01032024_090114.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,400.2643

Underlying: Common Stock · 2,147.651 shares

Expires not disclosed

F1 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F2 · security: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $14.90 on December 29, 2023.

F3 · derivative.exercise_price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $14.90 on December 29, 2023.

F3 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
November 30, 2023 Filed Dec 4, 2023 22:28 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantCommon Stock 20,374 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-015773 · form4-12042023_101231.xml · nonDerivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,290

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
September 29, 2023 Filed Oct 3, 2023 20:36 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 2,846.9751 $11.24 $32,000.00
Disclosure

SEC source: 0001415889-23-013883 · form4-10032023_081023.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,252.6133

Underlying: Common Stock · 2,846.9751 shares

Expires not disclosed

F1 · derivative.exercise_price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · derivative.exercise_price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $11.24 on September 29, 2023.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
June 30, 2023 Filed Jul 5, 2023 21:16 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 3,180.9145 $10.06 $32,000.00
Disclosure

SEC source: 0001415889-23-010792 · form4-07052023_090758.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,405.6382

Underlying: Common Stock · 3,180.9145 shares

Expires not disclosed

F1 · derivative.exercise_price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · derivative.exercise_price: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $10.06 on June 30, 2023.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 20:31 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 3,404.2553 $9.40 $32,000.00
Disclosure

SEC source: 0001415889-23-006020 · form4-04042023_080434.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,224.7237

Underlying: Common Stock · 3,404.2553 shares

Expires not disclosed

F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $9.40 on March 31, 2023.

F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $9.40 on March 31, 2023.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
March 14, 2023 Filed Mar 15, 2023 20:21 UTC Elanco Animal Health Inc ELAN · Entity 3457 PurchaseCommon Stock 5,000 $9.55 $47,750.00
Disclosure

SEC source: 0001415889-23-004945 · form4-03152023_080315.xml · nonDerivative · entry 2

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Revocable Trust

Disclosed balance after: 165,000

Read SEC document
March 13, 2023 Filed Mar 15, 2023 20:21 UTC Elanco Animal Health Inc ELAN · Entity 3457 PurchaseCommon Stock 5,000 $9.46 $47,288.00
Disclosure

SEC source: 0001415889-23-004945 · form4-03152023_080315.xml · nonDerivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Revocable Trust

Disclosed balance after: 160,000

F1 · price: Reflects the weighted average price of 5,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on March 13, 2023 with purchase prices ranging from $9.455 to $9.4578 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
March 03, 2023 Filed Mar 7, 2023 22:47 UTC Elanco Animal Health Inc ELAN · Entity 3457 PurchaseCommon Stock 10,000 $11.13 $111,300.00
Disclosure

SEC source: 0001415889-23-004438 · form4-03072023_100323.xml · nonDerivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Revocable Trust

Disclosed balance after: 155,000

Read SEC document
December 30, 2022 Filed Jan 3, 2023 22:10 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 872.8863 $12.22 $10,666.67
Disclosure

SEC source: 0001415889-23-000093 · form4-01032023_100141.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,820.4684

Underlying: Common Stock · 872.8863 shares

Expires not disclosed

F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.22 on December 30, 2022.

F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.22 on December 30, 2022.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
November 30, 2022 Filed Dec 2, 2022 22:05 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 828.8011 $12.87 $10,666.67
Disclosure

SEC source: 0001415889-22-011973 · form4-12022022_101200.xml · derivative · entry 4

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,947.5821

Underlying: Common Stock · 828.8011 shares

Expires not disclosed

F2 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F4 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.87 on November 30, 2022.

F2 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F4 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.87 on November 30, 2022.

F2 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
November 30, 2022 Filed Dec 2, 2022 22:05 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantCommon Stock 18,649 $0.00 $0.00
Disclosure

SEC source: 0001415889-22-011973 · form4-12022022_101200.xml · nonDerivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,916

F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
October 31, 2022 Filed Nov 2, 2022 20:29 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 808.6937 $13.19 $10,666.67
Disclosure

SEC source: 0001415889-22-010998 · form4-11022022_011111.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,118.781

Underlying: Common Stock · 808.6937 shares

Expires not disclosed

F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $13.19 on October 31, 2022.

F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $13.19 on October 31, 2022.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
September 30, 2022 Filed Oct 4, 2022 21:50 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 859.5222 $12.41 $10,666.67
Disclosure

SEC source: 0001415889-22-010279 · form4-10042022_021006.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,310.0873

Underlying: Common Stock · 859.5222 shares

Expires not disclosed

F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.41 on September 30, 2022.

F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.41 on September 30, 2022.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
September 09, 2022 Filed Sep 9, 2022 20:31 UTC Elanco Animal Health Inc ELAN · Entity 3457 PurchaseCommon Stock 20,000 $15.18 $303,614.00
Disclosure

SEC source: 0001415889-22-009498 · form4-09092022_010912.xml · nonDerivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Revocable Trust

Disclosed balance after: 145,000

F1 · shares: Reflects the weighted average price of 20,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on September 9, 2022 with purchase prices ranging from $15.105 to $15.2599 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
August 31, 2022 Filed Sep 2, 2022 20:07 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 705.0013 $15.13 $10,666.67
Disclosure

SEC source: 0001415889-22-009259 · form4-09022022_010912.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,450.5651

Underlying: Common Stock · 705.0013 shares

Expires not disclosed

F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $15.13 on August 31, 2022.

F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $15.13 on August 31, 2022.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
July 29, 2022 Filed Aug 2, 2022 20:37 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 526.4891 $20.26 $10,666.67
Disclosure

SEC source: 0001415889-22-008120 · form4-08022022_010823.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,745.5638

Underlying: Common Stock · 526.4891 shares

Expires not disclosed

F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $20.26 on July 29, 2022.

F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $20.26 on July 29, 2022.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
June 30, 2022 Filed Jul 5, 2022 20:35 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 543.3861 $19.63 $10,666.67
Disclosure

SEC source: 0001415889-22-007343 · form4-07052022_010713.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,219.0747

Underlying: Common Stock · 543.3861 shares

Expires not disclosed

F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $19.63 on June 30, 2022.

F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $19.63 on June 30, 2022.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
May 31, 2022 Filed Jun 2, 2022 23:54 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 450.0704 $23.70 $10,666.67
Disclosure

SEC source: 0001415889-22-006046 · form4-06022022_040646.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,675.6886

Underlying: Common Stock · 450.0704 shares

Expires not disclosed

F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $23.70 on May 31, 2022.

F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $23.70 on May 31, 2022.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
May 20, 2022 Filed May 24, 2022 20:33 UTC Elanco Animal Health Inc ELAN · Entity 3457 PurchaseCommon Stock 10,000 $23.33 $233,269.00
Disclosure

SEC source: 0001415889-22-005599 · form4-05242022_010528.xml · nonDerivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Revocable Trust

Disclosed balance after: 125,000

F1 · price: Reflects the weighted average price of 10,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on May 20, 2022 with purchase prices ranging from $23.19 to $23.3393 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
April 29, 2022 Filed May 3, 2022 21:34 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 421.4409 $25.31 $10,666.67
Disclosure

SEC source: 0001415889-22-004545 · form4-05032022_020555.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,225.6182

Underlying: Common Stock · 421.4409 shares

Expires not disclosed

F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $25.31 on April 29, 2022.

F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $25.31 on April 29, 2022.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
March 31, 2022 Filed Apr 4, 2022 21:53 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 408.8413 $26.09 $10,666.67
Disclosure

SEC source: 0001415889-22-003754 · form4-04042022_020419.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,804.1773

Underlying: Common Stock · 408.8413 shares

Expires not disclosed

F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $26.09 on March 31, 2022.

F1 · price: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $26.09 on March 31, 2022.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
March 02, 2022 Filed Mar 2, 2022 22:51 UTC Elanco Animal Health Inc ELAN · Entity 3457 PurchaseCommon Stock 5,000 $29.00 $145,000.00
Disclosure

SEC source: 0001179110-22-001943 · edgar.xml · nonDerivative · entry 2

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Revocable Trust

Disclosed balance after: 115,000

F2 · price: Reflects the weighted average price of 5,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on March 2, 2022 with purchase prices ranging from $28.88 to $29.12 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 22:51 UTC Elanco Animal Health Inc ELAN · Entity 3457 PurchaseCommon Stock 5,000 $28.66 $143,322.50
Disclosure

SEC source: 0001179110-22-001943 · edgar.xml · nonDerivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Revocable Trust

Disclosed balance after: 110,000

F1 · price: Reflects the weighted average price of 5,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on March 1, 2022 with purchase prices ranging from $28.43 to $28.899 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 22:51 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 375.4548 $28.41 $10,666.67
Disclosure

SEC source: 0001179110-22-001943 · edgar.xml · derivative · entry 5

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,395.336

Underlying: Common Stock · 375.4548 shares

Expires not disclosed

F3 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F4 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F5 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.41 on February 28, 2022.

F4 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F5 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.41 on February 28, 2022.

F3 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
January 31, 2022 Filed Feb 3, 2022 01:36 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 409.6263 $26.04 $10,666.67
Disclosure

SEC source: 0001179110-22-000725 · edgar.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,019.8812

Underlying: Common Stock · 409.6263 shares

Expires not disclosed

F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $26.04 on January 31, 2022.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $26.04 on January 31, 2022.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 22:49 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 751.703 $28.38 $21,333.33
Disclosure

SEC source: 0001179110-22-000133 · edgar.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,610.2549

Underlying: Common Stock · 751.703 shares

Expires not disclosed

F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.38 on December 31, 2021.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.38 on December 31, 2021.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
November 30, 2021 Filed Dec 2, 2021 22:16 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 742.2871 $28.74 $21,333.33
Disclosure

SEC source: 0001179110-21-010543 · edgar.xml · derivative · entry 4

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,858.5519

Underlying: Common Stock · 742.2871 shares

Expires not disclosed

F3 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F4 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F5 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.74 on November 30, 2021.

F4 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F5 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.74 on November 30, 2021.

F3 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
November 30, 2021 Filed Dec 2, 2021 22:16 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantCommon Stock 7,307 $0.00 $0.00
Disclosure

SEC source: 0001179110-21-010543 · edgar.xml · nonDerivative · entry 2

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,267

F2 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.

Read SEC document
November 30, 2021 Filed Dec 2, 2021 22:16 UTC Elanco Animal Health Inc ELAN · Entity 3457 PurchaseCommon Stock 10,000 $29.38 $293,794.00
Disclosure

SEC source: 0001179110-21-010543 · edgar.xml · nonDerivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Revocable Trust

Disclosed balance after: 105,000

F1 · price: Reflects the weighted average price of 10,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on November 30, 2021 with purchase prices ranging from $29.3587 to $29.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Read SEC document
November 15, 2021 Filed Nov 17, 2021 21:09 UTC Elanco Animal Health Inc ELAN · Entity 3457 PurchaseCommon Stock 5,000 $31.79 $158,934.50
Disclosure

SEC source: 0001179110-21-010212 · edgar.xml · nonDerivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Revocable Trust

Disclosed balance after: 95,000

Read SEC document
October 29, 2021 Filed Nov 2, 2021 20:30 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 471.4112 $32.88 $15,500.00
Disclosure

SEC source: 0001179110-21-009769 · edgar.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,116.2648

Underlying: Common Stock · 471.4112 shares

Expires not disclosed

F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.88 on October 29, 2021.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.88 on October 29, 2021.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
September 30, 2021 Filed Oct 4, 2021 20:19 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 486.0458 $31.89 $15,500.00
Disclosure

SEC source: 0001179110-21-009147 · edgar.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,644.8536

Underlying: Common Stock · 486.0458 shares

Expires not disclosed

F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $31.89 on September 30, 2021.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $31.89 on September 30, 2021.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
August 31, 2021 Filed Sep 2, 2021 20:19 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 464.3499 $33.38 $15,500.00
Disclosure

SEC source: 0001235110-21-000026 · edgar.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,158.8078

Underlying: Common Stock · 464.3499 shares

Expires not disclosed

F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company;s Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $33.38 on August 31, 2021.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company;s Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $33.38 on August 31, 2021.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
August 16, 2021 Filed Aug 17, 2021 20:57 UTC Elanco Animal Health Inc ELAN · Entity 3457 PurchaseCommon Stock 8,000 $31.45 $251,592.00
Disclosure

SEC source: 0000950138-21-000416 · edgar.xml · nonDerivative · entry 2

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Revocable Trust

Disclosed balance after: 90,000

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $31.2983 to $31.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Read SEC document
August 13, 2021 Filed Aug 17, 2021 20:57 UTC Elanco Animal Health Inc ELAN · Entity 3457 PurchaseCommon Stock 2,000 $30.75 $61,490.00
Disclosure

SEC source: 0000950138-21-000416 · edgar.xml · nonDerivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Revocable Trust

Disclosed balance after: 82,000

Read SEC document
July 30, 2021 Filed Aug 3, 2021 20:46 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 425.0069 $36.37 $15,457.50
Disclosure

SEC source: 0000950138-21-000404 · edgar.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,694.4579

Underlying: Common Stock · 425.0069 shares

Expires not disclosed

F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $36.37 on July 30, 2021.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $36.37 on July 30, 2021.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
June 30, 2021 Filed Jul 2, 2021 20:41 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 446.8146 $34.69 $15,500.00
Disclosure

SEC source: 0000950138-21-000370 · edgar.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,269.451

Underlying: Common Stock · 446.8146 shares

Expires not disclosed

F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $34.69 on June 30, 2021.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $34.69 on June 30, 2021.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
May 28, 2021 Filed Jun 2, 2021 20:53 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 430.7949 $35.98 $15,500.00
Disclosure

SEC source: 0000950138-21-000317 · edgar.xml · derivative · entry 4

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,822.6364

Underlying: Common Stock · 430.7949 shares

Expires not disclosed

F2 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F3 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F4 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $35.98 on May 28, 2021.

F3 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F4 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $35.98 on May 28, 2021.

F2 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
May 11, 2021 Filed May 12, 2021 21:54 UTC Elanco Animal Health Inc ELAN · Entity 3457 PurchaseCommon Stock 25,000 $32.44 $811,000.00
Disclosure

SEC source: 0000950138-21-000308 · edgar.xml · nonDerivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Revocable trust

Disclosed balance after: 70,000

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $32.3000 to $32.5699, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Read SEC document
March 31, 2021 Filed Apr 2, 2021 21:55 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 526.3158 $29.45 $15,500.00
Disclosure

SEC source: 0000950138-21-000246 · edgar.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,903.0367

Underlying: Common Stock · 526.3158 shares

Expires not disclosed

F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $29.45 on March 31, 2021.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $29.45 on March 31, 2021.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
March 31, 2021 Filed May 3, 2021 23:57 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 488.8048 $31.71 $15,500.00
Disclosure

SEC source: 0000950138-21-000290 · edgar.xml · derivative · entry 1

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,391.8415

Underlying: Common Stock · 488.8048 shares

Expires not disclosed

F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $31.71 on April 30, 2021.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $31.71 on April 30, 2021.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 21:56 UTC Elanco Animal Health Inc ELAN · Entity 3457 GrantDeferred Stock Units · Derivative 471.6981 $32.86 $15,500.00
Disclosure

SEC source: 0000950138-21-000162 · edgar.xml · derivative · entry 2

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,376.7209

Underlying: Common Stock · 471.6981 shares

Expires not disclosed

F1 · security: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F4 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.86 on February 26, 2021.

F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.

F4 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.86 on February 26, 2021.

F1 · derivative.exercise_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

F1 · derivative.expiration_date: Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.

Read SEC document
February 03, 2021 Filed Feb 5, 2021 13:37 UTC EDGEWELL PERSONAL CARE Co EPC · Entity 4787 OtherRestricted Stock Equivalents 2-6-2020 · Derivative 3,944 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-21-007992 · doc4.xml · derivative · entry 7

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,944 shares

Expires not disclosed

F2 · derivative.exercise_date: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021.

F2 · derivative.expiration_date: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021.

Read SEC document
February 03, 2021 Filed Feb 5, 2021 13:37 UTC EDGEWELL PERSONAL CARE Co EPC · Entity 4787 OtherRestricted Stock Equivalents 2-1-2019 · Derivative 3,156 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-21-007992 · doc4.xml · derivative · entry 6

HOOVER R DAVID · CIK 0001186033 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,156 shares

Expires not disclosed

F2 · derivative.exercise_date: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021.

F2 · derivative.expiration_date: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.